Kenvue Inc. (KVUE) shares advanced 2.55% to $18.88 following the release of fourth-quarter earnings that surpassed analyst expectations. The consumer health company reported adjusted earnings per share of $0.27, exceeding consensus estimates of $0.22, a performance that prompted several analysts to elevate their price targets on the stock.
The company is maintaining its strategic trajectory toward a planned $48.7 billion merger with Kimberly-Clark, which is anticipated to close during the second half of 2026. In parallel, Kenvue is executing a comprehensive restructuring program that will result in a 3.5% reduction in its global workforce and generate approximately $250 million in pre-tax charges throughout 2026 as the company optimizes operations ahead of the combination.
The earnings beat reflects operational momentum at the company, which manufactures consumer health and personal care products. The restructuring initiative is designed to enhance cost efficiency and create synergies in preparation for the integration with Kimberly-Clark, a leading manufacturer of personal care products.